Ilika PLC (AIM:IKA, OTCQX:ILIKF) has started production of its solid-state micro-batteries in the United States after completing the final stage of qualification at a partner facility in Massachusetts.
The AIM-listed company said its Stereax M300 line at Cirtec Medical’s site in Lowell had passed technical checks, allowing manufacturing to move ahead for testing and first deliveries.
The Stereax batteries are designed for use in implantable medical devices, where long life, safety and compact size are critical.
Solid-state batteries use a solid electrolyte rather than a liquid one, which allows for miniaturisation while reducing the risk of leakage.
The milestone triggers a ten-year production agreement signed in 2023 with Cirtec Medical, a contract manufacturer for the healthcare sector.
The Lowell facility is equipped with precision deposition and patterning systems needed for medical-grade components.
CEO Graeme Purdy said: "This manufacturing milestone demonstrates the successful technology transfer of our proprietary Stereax platform to commercial production scale.
"The strong customer interest we're seeing validates the market need for miniaturised solid-state batteries in medical devices.
"With the combination of Ilika's expertise and Cirtec Medical's world-class manufacturing capabilities, we are well-positioned to meet growing customer demand in 2025 and beyond."